Gunderson Dettmer advised TeneoTwo on the deal.TeneoTwo, a developer of therapeutic antibodies, announced its pending acquisition by AstraZeneca, a bio-pharmaceutical company that focuses on the discovery, development…
AstraZeneca’s Acquisition of TeneoTwo
